BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9178855)

  • 1. The involvement of calmodulin and Ca2+/calmodulin-dependent protein kinase II in the circadian rhythms controlled by the suprachiasmatic nucleus.
    Fukushima T; Shimazoe T; Shibata S; Watanabe A; Ono M; Hamada T; Watanabe S
    Neurosci Lett; 1997 May; 227(1):45-8. PubMed ID: 9178855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diurnal, circadian and photic regulation of calcium/calmodulin-dependent kinase II and neuronal nitric oxide synthase in the hamster suprachiasmatic nuclei.
    Agostino PV; Ferreyra GA; Murad AD; Watanabe Y; Golombek DA
    Neurochem Int; 2004 Jun; 44(8):617-25. PubMed ID: 15016477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of calcium-calmodulin protein kinase but not mitogen-activated protein kinase in light-induced phase delays and Per gene expression in the suprachiasmatic nucleus of the hamster.
    Yokota S; Yamamoto M; Moriya T; Akiyama M; Fukunaga K; Miyamoto E; Shibata S
    J Neurochem; 2001 Apr; 77(2):618-27. PubMed ID: 11299324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular application of calmidazolium increases Ca2+ current through activation of protein kinase A in cultured vascular smooth muscle cells.
    Sunagawa M; Yokoshiki H; Seki T; Sperelakis N
    J Vasc Res; 1998; 35(5):303-9. PubMed ID: 9789110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
    Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.
    Williams CL; Phelps SH; Porter RA
    Biochem Pharmacol; 1996 Mar; 51(5):707-15. PubMed ID: 8615909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin.
    Fukunaga K; Horikawa K; Shibata S; Takeuchi Y; Miyamoto E
    J Neurosci Res; 2002 Dec; 70(6):799-807. PubMed ID: 12444602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian responses to light: the calmodulin connection.
    Golombek DA; Ralph MR
    Neurosci Lett; 1995 Jun; 192(2):101-4. PubMed ID: 7675313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nociceptin and opioid receptor like 1 on entrainment function in the rat suprachiasmatic nucleus.
    Sugino T; Shimazoe T; Ikeda M; Watanabe S
    Neuroscience; 2006; 137(2):537-44. PubMed ID: 16310969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of calmodulin and protein kinase C in the regulation of K+ transport by carbachol across the rat distal colon.
    Heinke B; Ribeiro R; Diener M
    Eur J Pharmacol; 1999 Jul; 377(1):75-80. PubMed ID: 10448929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization.
    Takano H; Fukushi H; Morishima Y; Shirasaki Y
    Brain Res; 2003 Feb; 962(1-2):41-7. PubMed ID: 12543454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic signalling in the rodent neonatal suprachiasmatic nucleus identifies a role for protein kinase A and mitogen-activated protein kinase in circadian entrainment.
    Schurov IL; Hepworth TJ; Hastings MH
    Eur J Neurosci; 2002 Jan; 15(2):223-32. PubMed ID: 11849290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calmodulin inhibitors produce phase shifts of circadian rhythms in vivo and in vitro.
    Shibata S; Moore RY
    J Biol Rhythms; 1994; 9(1):27-41. PubMed ID: 7949304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of calcium on the uptake of glutamate by synaptosomes: possible involvement of two different mechanisms.
    Zhu BG; Chen YZ; Xing BR
    J Neural Transm (Vienna); 1999; 106(3-4):257-64. PubMed ID: 10392534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KN-62, an inhibitor of Ca2+/calmodulin kinase II, attenuates circadian responses to light.
    Golombek DA; Ralph MR
    Neuroreport; 1994 Aug; 5(13):1638-40. PubMed ID: 7819537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcium, calmodulin, protein kinase C and protein tyrosine kinases on volume-activated taurine efflux in human erythroleukemia cells.
    Huang CC; Chang CB; Liu JY; Basavappa S; Lim PH
    J Cell Physiol; 2001 Dec; 189(3):316-22. PubMed ID: 11748589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha1-adrenergic receptor activation of c-fos expression in transfected rat-1 fibroblasts: role of Ca2+.
    Chen J; Lin R; Hu ZW; Hoffman BB
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1376-84. PubMed ID: 10336529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role for Ca(2+)/calmodulin-dependent protein kinase IV during pancreatic acinar stimulus-secretion coupling.
    Yoshida H; Nozu F; Lankisch TO; Mitamura K; Owyang C; Tsunoda Y
    Biochim Biophys Acta; 2000 Jun; 1497(1):155-67. PubMed ID: 10838169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct synaptic loci of Ca2+/calmodulin-dependent protein kinase II necessary for long-term potentiation and depression.
    Stanton PK; Gage AT
    J Neurophysiol; 1996 Sep; 76(3):2097-101. PubMed ID: 8890320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of omega-conotoxin GVIA, nimodipine, calmidazolium and KN-62 injected intrathecally on the antinociception induced by beta-endorphin, morphine and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin administered intracerebroventricularly in the mouse.
    Suh HW; Song DK; Choi SR; Huh SO; Kim YH
    J Pharmacol Exp Ther; 1997 Aug; 282(2):961-6. PubMed ID: 9262364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.